Modulation of Astrocyte Reactivity Improves Functional Deficits in Mouse Models of Alzheimer's Disease

Astrocyte reactivity and neuroinflammation are hallmarks of CNS pathological conditions such as Alzheimer's disease. However, the specific role of reactive astrocytes is still debated. This controversy may stem from the fact that most strategies used to modulate astrocyte reactivity and explore its contribution to disease outcomes have only limited specificity. Moreover, reactive astrocytes are now emerging as heterogeneous cells and all types of astrocyte reactivity may not be controlled efficiently by such strategies.Here, we used cell type-specific approaches in vivo and identified the JAK2-STAT3 pathway, as necessary and sufficient for the induction and maintenance of astrocyte reactivity. Modulation of this cascade by viral gene transfer in mouse astrocytes efficiently controlled several morphological and molecular features of reactivity. Inhibition of this pathway in mouse models of Alzheimer's disease improved three key pathological hallmarks by reducing amyloid deposition, improving spatial learning and restoring synaptic deficits.In conclusion, the JAK2-STAT3 cascade operates as a master regulator of astrocyte reactivity in vivo. Its inhibition offers new therapeutic opportunities for Alzheimer's disease.

Citing Articles

Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer's disease progression.

Lana D, Ugolini F, Iovino L, Attorre S, Giovannini M Front Cell Neurosci. 2025; 18():1512985.

PMID: 39835288 PMC: 11743640. DOI: 10.3389/fncel.2024.1512985.

Astrocytes in aging.

Labarta-Bajo L, Allen N Neuron. 2025; 113(1):109-126.

PMID: 39788083 PMC: 11735045. DOI: 10.1016/j.neuron.2024.12.010.

regionalpcs improve discovery of DNA methylation associations with complex traits.

Eulalio T, Sun M, Gevaert O, Greicius M, Montine T, Nachun D Nat Commun. 2025; 16(1):368.

PMID: 39753567 PMC: 11698866. DOI: 10.1038/s41467-024-55698-6.

Neuroprotective Effects of STAT3 Inhibitor on Hydrogen Peroxide-Induced Neuronal Cell Death via the ERK/CREB Signaling Pathway.

Kim S, Kwon Y, Seo E, Lee H, Sohn J, Shin H Neurochem Res. 2024; 50(1):52.

PMID: 39648181 PMC: 11625690. DOI: 10.1007/s11064-024-04252-3.

Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer's disease.

Phillips J, Winfree R, Seto M, Schneider J, Bennett D, Dumitrescu L Acta Neuropathol. 2024; 148(1):69.

PMID: 39580758 PMC: 11586308. DOI: 10.1007/s00401-024-02828-5.

References

Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K . Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med. 2006; 12(7):829-34. DOI: 10.1038/nm1425. View

Ben Haim L, Carrillo-de Sauvage M, Ceyzeriat K, Escartin C . Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 2015; 9:278. PMC: 4522610. DOI: 10.3389/fncel.2015.00278. View

Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L . Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol. 1996; 40(5):759-66. DOI: 10.1002/ana.410400512. View

Kang W, Hebert J . Signaling pathways in reactive astrocytes, a genetic perspective. Mol Neurobiol. 2011; 43(3):147-54. PMC: 3087829. DOI: 10.1007/s12035-011-8163-7. View

Panatier A, Theodosis D, Mothet J, Touquet B, Pollegioni L, Poulain D . Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell. 2006; 125(4):775-84. DOI: 10.1016/j.cell.2006.02.051. View

Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J . Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004; 10(7):719-26. DOI: 10.1038/nm1058. View

Krauthausen M, Kummer M, Zimmermann J, Reyes-Irisarri E, Terwel D, Bulic B . CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model. J Clin Invest. 2014; 125(1):365-78. PMC: 4382235. DOI: 10.1172/JCI66771. View

Oeckl P, Lattke M, Wirth T, Baumann B, Ferger B . Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP. Neurobiol Dis. 2012; 48(3):481-7. DOI: 10.1016/j.nbd.2012.06.010. View

10.

Marchetti C, Marie H . Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?. Rev Neurosci. 2011; 22(4):373-402. DOI: 10.1515/RNS.2011.035. View

11.

Rothhammer V, Mascanfroni I, Bunse L, Takenaka M, Kenison J, Mayo L . Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016; 22(6):586-97. PMC: 4899206. DOI: 10.1038/nm.4106. View

12.

Delekate A, Fuchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold G . Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model. Nat Commun. 2014; 5:5422. DOI: 10.1038/ncomms6422. View

13.

OCallaghan J, Kelly K, VanGilder R, Sofroniew M, Miller D . Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity. PLoS One. 2014; 9(7):e102003. PMC: 4098997. DOI: 10.1371/journal.pone.0102003. View

14.

Tyzack G, Hall C, Sibley C, Cymes T, Forostyak S, Carlino G . A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat Commun. 2017; 8(1):1164. PMC: 5660125. DOI: 10.1038/s41467-017-01283-z. View

15.

Thal D, Hartig W, SCHOBER R . Diffuse plaques in the molecular layer show intracellular A beta(8-17)-immunoreactive deposits in subpial astrocytes. Clin Neuropathol. 1999; 18(5):226-31. View

16.

Hardy J, Higgins G . Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992; 256(5054):184-5. DOI: 10.1126/science.1566067. View

17.

Jo S, Yarishkin O, Hwang Y, Chun Y, Park M, Woo D . GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat Med. 2014; 20(8):886-96. PMC: 8385452. DOI: 10.1038/nm.3639. View

18.

Sompol P, Furman J, Pleiss M, Kraner S, Artiushin I, Batten S . Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice. J Neurosci. 2017; 37(25):6132-6148. PMC: 5481945. DOI: 10.1523/JNEUROSCI.0877-17.2017. View

19.

Stephan A, Barres B, Stevens B . The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012; 35:369-89. DOI: 10.1146/annurev-neuro-061010-113810. View

20.

Zamanian J, Xu L, Foo L, Nouri N, Zhou L, Giffard R . Genomic analysis of reactive astrogliosis. J Neurosci. 2012; 32(18):6391-410. PMC: 3480225. DOI: 10.1523/JNEUROSCI.6221-11.2012. View